Skip to content

Clinical trials

Cushing Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cushing Syndrome Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20041
20051
20061
20072
20081
20092
20101
20113
20122
20132
20145
20155
20167
20179
20189
20193
20204
20215
20227
202312
20248
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Recruiting29
Unknown status19
Terminated7
Active, not recruiting6
Not yet recruiting4
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Corcept Therapeutics16
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)9
Haukeland University Hospital5
RECORDATI GROUP5
Mayo Clinic4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
HRA Pharma3
Istituto Auxologico Italiano3
National Center for Research Resources (NCRR)3
National Institute of Mental Health (NIMH)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cushing Syndrome117
ACTH Syndrome, Ectopic22
Pituitary ACTH Hypersecretion18
Hyperaldosteronism14
Adrenal Insufficiency10
Endocrine System Diseases10
Pheochromocytoma10
Adrenal Cortex Neoplasms9
Adrenocortical Carcinoma9
Diabetes Mellitus, Type 28

Trials

Showing 26 to 50 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.